Angiotech On Track To Building Drug-Loaded Device Franchise – CEO Hunter
This article was originally published in The Gray Sheet
Executive Summary
Angiotech's combination product pipeline includes drug-loaded versions of the CoSeal surgical sealant, CoStasis surgical hemostat and Adhibit adhesion barrier, CEO William Hunter stated in an Aug. 17 earnings call